AMCYTE PHARMA INC
AMCYTE PHARMA INC (United States) holds 1 active US FDA Type II Drug Master File. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “AMCYTE PHARMA INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/amcyte-pharma-inc
Overview
AMCYTE PHARMA INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering RECOMBINANT INTERLEUKIN-2 (ALDESLEUKIN).
API / Drug Master Files
AMCYTE PHARMA INC holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- RECOMBINANT INTERLEUKIN-2 (ALDESLEUKIN)Active2019-01-31
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2022-01-03
FDA Warning Letter (drug product)
Is this AMCYTE PHARMA INC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.